Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells in Serum-Free Medium-Reference-Cited by-同舟云学术

Production of Inactivated Influenza H5N1 Vaccines from MDCK Cells in Serum-Free Medium

Published:2011-01-24 Issue:1 Volume:6 Page:e14578
ISSN:1932-6203
Container-title:PLoS ONE
language:en
Short-container-title:PLoS ONE

Author:

Hu Alan Yung-Chih,Tseng Yu-Fen,Weng Tsai-Chuan,Liao Chien-Chun,Wu Johnson,Chou Ai-Hsiang,Chao Hsin-Ju,Gu Anna,Chen Janice,Lin Su-Chen,Hsiao Chia-Hsin,Wu Suh-Chin,Chong Pele

Publisher

Public Library of Science (PLoS)

Subject

Multidisciplinary

Reference29 articles.

1. Cumulative Number of Confirmed Human Cases of Avian Influenza A/(H5N1) Reported to WHO 5 January 2011.,2011

2. Comparison of large-scale mammalian cell culture systems with egg culture for the production of influenza virus A vaccine strains.;JA Tree;Vaccine,2001

3. Metabolism of MDCK cells during cell growth and influenza virus production in large-scale microcarrier culture.;Y Genzel;Vaccine,2004

4. Microcarrier-based MDCK cell culture system for the production of influenza H5N1 vaccines.;AY-C Hu;Vaccine,2008

5. Development of a mammalian cell (Vero) derived candidate influenza virus vaccine.;O Kistner;Vaccine,1998

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Engineering a replication-incompetent viral vector for the delivery of therapeutic RNA in crustaceans;PNAS Nexus;2023-08-23

2. Influenza Vaccine: An Engineering Vision from Virological Importance to Production;Biotechnology and Bioprocess Engineering;2022-10

3. Towards integrated production of an influenza A vaccine candidate with MDCK suspension cells;Biotechnology and Bioengineering;2021-07-20

4. Optimization of Vero Cells Grown on a Polymer Fiber Carrier in a Disposable Bioreactor for Inactivated Coxsackievirus A16 Vaccine Development;Vaccines;2021-06-07

5. Cell-based influenza vaccine: current production, halal status assessment, and recommendations towards Islamic-compliant manufacturing;Human Vaccines & Immunotherapeutics;2021-02-04